We are live on ! Find out more
DMPV

Delphi Management Partners VIII Portfolio holdings

AUM $138M
1-Year Est. Return 56.74%
This Fund
S&P 500
This Quarter Est. Return
+15.37%
1 Year Est. Return
+56.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$138M
AUM Growth
+$11.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 96.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
1
Tandem Diabetes Care
TNDM
$1.17B
$119M 86.22%
1,000,000
KPTI icon
2
Karyopharm Therapeutics
KPTI
$216M
$13.2M 9.51%
150,867
CALA
3
DELISTED
Calithera Biosciences, Inc
CALA
$5.29M 3.82%
121,335
MREO
4
Mereo BioPharma
MREO
$49.5M
$621K 0.45%
256,734

Similar funds

Delphi Management Partners VIII's Q3 2021 Portfolio in Review

As of Q3 2021, Delphi Management Partners VIII held 4 positions worth $138M, up 9.3% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Delphi Management Partners VIII opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.

  • Delphi Management Partners VIII's ten largest holdings make up 100% of its $138M portfolio in Q3 2021.
  • Delphi Management Partners VIII opened 0 new positions and closed 0 in Q3 2021.
  • Delphi Management Partners VIII's portfolio value rose 9.3% quarter-over-quarter to $138M.

Based on Delphi Management Partners VIII's 13F filing for Q3 2021, filed 15 Nov 2021.